From USFDA
Dr Reddy's Laboratories has received an Establishment Inspection Report from the USFDA following closure of audit of its API manufacturing plant at Miryalaguda. The Company was issued a form 483 with three observations subsequent to the audit of the said unit in February 2017.Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
